In a study, blocking the immune system complement protein C3 was shown to reduce MS disease severity in older mice but not in ...

An Indian review reveals how macrophages are reprogrammed inside breast tumours, helping cancer grow and spread while opening new treatment pathways.

Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of RLYB116 for complement-mediated diseases, with its initial ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that recapitulates key structural, functional, and immunological features of ...

Leveraging human organoid-based mechanistic investigation, researchers reveal how an immunosuppressive drug, antithymocyte ...

This Rare Disease Day, observed on Feb. 28 worldwide, the American Kidney Fund is committed to improving the understanding of ...

Indian researchers reveal how immune cells 'betray' the body, aiding breast cancer spread and suggesting new treatment ...

Bats have been increasingly identified as hosts for zoonotic pathogens, including but not limited to viruses, bacteria, and protozoa. With few exceptions, ...

Medically reviewed by Michael Menna, DO Complement 3 glomerulopathy is a rare disease caused by a buildup of proteins in the kidneys. The prognosis and life expectancy for C3G depends on the disease ...

Costa Mesa, California - January 29, 2026 - PRESSADVANTAGE - French Bulldogs are one of the most popular companion dog ...